Kazakhstan vs New Zealand: New cases tested for RR-/MDR-TB
Kazakhstan
100.0%
in 2024
New Zealand
100.0%
in 2014
Kazakhstan rank
1st
New Zealand rank
1st
New cases tested for RR-/MDR-TB over time
- Kazakhstan
- New Zealand
How they compare
Kazakhstan currently reports 100.0% against 100.0% in New Zealand, a difference of 0.0%.
The two have swapped places 2 times across 9 shared years of data; in 2006 it was New Zealand ahead.
Kazakhstan ranks 1st and New Zealand ranks 1st of 192 countries.
Across the 2 decades both report, Kazakhstan averaged higher in 1 and New Zealand in 1.
Head to head by decade
| Decade | Kazakhstan | New Zealand | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 73.0% | 100.0% | 27.0% | New Zealand |
| 2010s | 95.8% | 80.5% | 15.3% | Kazakhstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Kazakhstan or New Zealand?
- Kazakhstan, at 100.0% against 100.0% in New Zealand as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Kazakhstan and New Zealand?
- 0.0%, with Kazakhstan ahead.
- How many years of comparable data are there for Kazakhstan and New Zealand?
- 9 years are reported by both, from 2006 to 2014.
- How do Kazakhstan and New Zealand rank globally for new cases tested for rr-/mdr-tb?
- Kazakhstan ranks 1st and New Zealand ranks 1st of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.